Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial

Leukemia, Published online: 21 August 2023; doi:10.1038/s41375-023-02001-zGlasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial

Source: Leukemia - August 21, 2023 Category: Hematology Authors: Mikkael A. Sekeres Pau Montesinos Jan Novak Jianxiang Wang Deepa Jeyakumar Benjamin Tomlinson Jiri Mayer Erin Jou Tadeusz Robak David C. Taussig Herv é Dombret Akil Merchant Naveed Shaik Thomas O ’Brien Whijae Roh Xueli Liu Wendy Ma Christine G. DiRien Source Type: research